ライフサイエンスコーパス: total cholesterol

1 CI 0.76-1.21, p=0.688 per 1 unit increase in total cholesterol).

2 which was associated with blood pressure and total cholesterol.

3 d triglycerides but had no effect on LDLs or total cholesterol.

4 little effect on low-density lipoproteins or total cholesterol.

5 more than 40 years ago using an analysis of total cholesterol.

6 lipoprotein cholesterol, triglycerides, and total cholesterol.

7 for low-density lipoprotein cholesterol and total cholesterol.

8 h the levels of high-density lipoprotein and total cholesterol.

9 blood pressures, fasting blood glucose, and total cholesterol.

10 the observed trend in mean concentrations of total cholesterol.

11 lood pressure, smoking status, diabetes, and total cholesterol.

12 of the measurement of hydrogen peroxide and total cholesterol.

13 s and visceral adipose tissue, and increased total cholesterol.

14 high systolic blood pressure (SBP) and high total cholesterol.

15 (0.21 standard deviations, 95% CI 0.01-0.4), total cholesterol (0.21 standard deviations, 95% CI 0.03

16 and calcium caseinate significantly lowered total cholesterol [-0.26 mmol/L (P = 0.013) and -0.20 mm

17 istically significantly increased both serum total cholesterol (17 trials; net change: 11.2 mg/dL; 95

18 +/- 1 mm Hg, respectively; both P < 0.0008), total cholesterol (-17 +/- 4 mg/dL; P < 0.0001), non-HDL

19 Mean lipid values were as follows: total cholesterol: 177.3 +/- 33.1 mg/dl; LDL-C: 109.9 +/

20 s was 119.98 mg/dL (98.58-141.39 mg/dL); for total cholesterol, 184.74 mg/dL (178.17-191.31 mg/dL); f

21 younger (56.5 versus 67.5 years), had higher total cholesterol (188 versus 157 mg/dL), more insulin u

22 ls of fasting insulin (-6.37 IU/L; P = .02), total cholesterol (-19.51 mg/dL; P = .01), low-density l

23 0+/-2.7 versus 26.7+/-2.6 kg/m(2); P<0.001), total cholesterol (199+/-33 versus 192+/-29 mg/dL; P=0.0

24 perimental groups exhibited increases in: 1) total cholesterol, 2) low-density lipoprotein, and 3) hi

25 Abnormal lipid levels were found in 8.6% for total cholesterol, 22.5% for high-density lipoprotein-ch

26 (compared with the control, all P < 0.05) in total cholesterol [-3.9% (95% CI: -9.3%, 1.7%) compared

27 3] vs placebo and 34% [26-41] vs ezetimibe), total cholesterol (38% [32-44] vs placebo and 24% [16-31

28 Nut intake (per serving/d) lowered total cholesterol (-4.7 mg/dL; 95% CI: -5.3, -4.0 mg/dL)

29 24% decrease reflecting modest reductions in total cholesterol (-41 000), systolic blood pressure (-3

30 cluded 47 healthy men and women (mean +/- SD total cholesterol: 5.22 +/- 0.90 mmol/L) who substituted

31 ith MUFAs or n-6 PUFAs lowered fasting serum total cholesterol (-8.4% and -9.2%, respectively), low-d

32 Flaxseed had no attributable effects on total cholesterol (-8.51 mg/dL [-0.22 mmol/L]; 95% CI, -

33 re +26 mg/dl for triglycerides, -8 mg/dl for total cholesterol, -8 mg/dl for low-density lipoprotein

34 demia remission rates were 93.3% (28/30) for total cholesterol, 89.7% (26/29) for triglycerides, and

35 medications to changes in concentrations of total cholesterol among adults in the United States from

36 Mean concentrations of total cholesterol among adults in the United States have

37 bited a 32 and 44% decrease in the levels of total cholesterol and apolipoprotein B and approximately

38 of SRSF2 in gene regulation, accumulation of total cholesterol and bile acids was prominently observe

39 T2 gene deletions had lower accumulations of total cholesterol and CE in the liver compared with cont

40 -0.880, -0.023; P = 0.039) and a decrease in total cholesterol and HDL cholesterol (beta = 3.766; 95%

41 Total cholesterol and HDL-cholesterol concentrations wer

42 tolic blood pressure, mean concentrations of total cholesterol and high-density lipoprotein cholester

43 te intake of butter resulted in increases in total cholesterol and LDL cholesterol compared with the

44 Butter intake increased total cholesterol and LDL cholesterol more than did oliv

45 The dose-response between nut intake and total cholesterol and LDL cholesterol was nonlinear (P-n

46 ashews into typical American diets decreases total cholesterol and LDL cholesterol.

47 be a simple dietary strategy to help manage total cholesterol and LDL cholesterol.

48 Higher total cholesterol and LDL-C were associated with faster

49 HIV(+) men had similar baseline total cholesterol and LDL-C, but lower HDL-C and higher

50 L linuron and a negative correlation between total cholesterol and linuron treatment concentration.

51 rs (n=40) showed significantly higher plasma total cholesterol and low-density lipoprotein cholestero

52 ects tended to have higher concentrations of total cholesterol and low-density lipoprotein cholestero

53 level and increased to 139 mg/dL at 3 years; total cholesterol and low-density lipoprotein cholestero

54 Reduction of total cholesterol and low-density lipoprotein was signif

55 bolic abnormalities, including low levels of total cholesterol and low-density lipoprotein.

56 found that metformin markedly lowered plasma total cholesterol and TG levels, an effect mostly due to

57 Nef caused elevation of total cholesterol and triglyceride levels in the plasma

58 ss index, insulin, insulin resistance index, total cholesterol and triglyceride, and increasing high-

59 Secondary aim was to measure total cholesterol and triglycerides levels and insulin s

60 p-PLA2 and IL-6 levels, smaller increases in total cholesterol and triglycerides levels, a larger dec

61 ngly, arglabin also reduced plasma levels of total cholesterol and triglycerides to 41% and 42%, resp

62 in cholesterol), 14 (triglycerides), and 19 (total cholesterol and triglycerides).

63 and there were modest increases in levels of total cholesterol and triglycerides.

64 ndependently of glycemia or plasma levels of total cholesterol and triglycerides.

65 Systemic levels of total cholesterol and use of CLM were measured at study

66 lucose concentration, height, schizophrenia, total cholesterol, and (in females) age at menarche.

67 y lipoprotein cholesterol, 13 of 44 loci for total cholesterol, and 8 of 28 loci for triglycerides),

68 luded smoking, blood pressure, diabetes, and total cholesterol, and allowed the effects of sex and ag

69 Ideal CVH status for BMI, total cholesterol, and blood pressure was prevalent in y

70 (body mass index [BMI], healthy diet score, total cholesterol, and blood pressure).

71 ores of low-density lipoprotein-cholesterol, total cholesterol, and body mass index, which were succe

72 rst-trimester serum levels of triglycerides, total cholesterol, and C-reactive protein (CRP).

73 centage, waist circumference, triglycerides, total cholesterol, and C-reactive protein with periodont

74 g, blood pressure, high-density lipoprotein, total cholesterol, and diabetes mellitus) dichotomized t

75 associated with elevated triglycerides, high total cholesterol, and diabetes.

76 education, body mass index, current smoking, total cholesterol, and diabetes.

77 ependent of body mass index, blood pressure, total cholesterol, and fasting plasma glucose, better he

78 ipoprotein cholesterol, from 5.5 to 8.8% for total cholesterol, and from 5.7 to 8.5% for triglyceride

79 ion measurements of systolic blood pressure, total cholesterol, and high-density lipoprotein choleste

80 high BMI, high fasting plasma glucose, high total cholesterol, and low glomerular filtration rate; 7

81 obing was significantly associated with TGs, total cholesterol, and non-high-density lipoprotein chol

82 blood pressure, fitness, diabetes mellitus, total cholesterol, and smoking.

83 diastolic blood pressure, MCM6 and DARS for total cholesterol, and TRIB1 for triglycerides) that wer

84 lower levels of prolactin, fasting glucose, total cholesterol, and triglycerides than risperidone.

85 DL] and low-density lipoprotein-cholesterol, total cholesterol, and triglycerides) and lipoprotein su

86 between ages 6 and 24 years) of systolic BP, total-cholesterol, and smoking associated inversely with

87 High systolic BP, elevated serum total-cholesterol, and smoking from childhood were indep

88 s, systolic blood pressure, fasting glucose, total cholesterol, antihypertensive medication use, glom

89 protein (HDL) cholesterol, triglycerides and total cholesterol are heritable, modifiable risk factors

90 on (CE) fraction (esterified cholesterol vs. total cholesterol) as an alternative biomarker for liver

91 s in SLC22A3 and low-density lipoprotein and total cholesterol, associations that are missed by stand

92 The continuous variable of total cholesterol at 3 months post implantation and the

93 ing >/=3 g OBG/d to the diet reduces LDL and total cholesterol by 0.25 mmol/L and 0.30 mmol/L, respec

94 Patients with a greater increase in total cholesterol by 3 months post implantation had supe

95 statin further decreased LDL cholesterol and total cholesterol by 30.2+/-12.2% (P<0.01) and 18.2+/-9.

96 er reductions in systolic blood pressure and total cholesterol compared with usual care, placebo, or

97 ol ratio (P-interaction = 0.04) and elevated total cholesterol concentration (P-interaction = 0.02).

98 fatty acid oxidation; (5) increased hepatic total cholesterol concentration and decreased expression

99 olesterol concentration in each phase versus total cholesterol concentration in the sample increases

100 pid packing in the Lo phase was observed for total cholesterol concentration of 20 approximately 30%.

101 her cardiovascular risk factors, and fasting total cholesterol concentrations of 6.5 mmol/L or lower,

102 ay caused mice to excrete up to 60% of their total cholesterol content each day.

103 ition of the membrane that do not change the total cholesterol content, can significantly affect how

104 t 0.08, p < 0.001, in both ELSA and NPHSII), total cholesterol (correlation coefficient 0.46 and 0.34

105 LDL cholesterol and total cholesterol decreased significantly 6h after the c

106 independent of age, sex, race, BMI, smoking, total cholesterol, diastolic blood pressure, HbA1c, trea

107 s reaching genome-wide significance: two for total cholesterol (FN1 and SAMM50), two for HDL choleste

108 ted with smaller statin-induced reduction in total cholesterol from two independent clinical trials.

109 lycerides (from 103 to 75, 69 and 72 mg/dL), total cholesterol (from 267 to 160, 157 and 184 mg/dL),

110 current smoking, hypertension, diabetes, and total cholesterol >/=200 mg/dL) were evaluated in multiv

111 Decreases in serum total cholesterol >1 mmol/L >/=1 year prior to cancer di

112 The HYL group had total cholesterol >220 mg/dL or triglycerides >150 mg/dL

113 or for determination of free cholesterol and total cholesterol has been realized using a ZnO-CuO comp

114 d 0.7%, 9.5% and 18.9% of the variability of total cholesterol, HDL cholesterol and triglycerides in

115 ut there were no significant differences for total cholesterol, HDL-cholesterol, non-HDL-cholesterol,

116 .01 to 0.06 g/L; P = 0.05) and decreased the total cholesterol-HDL-C ratio by 0.27 (CI, -0.52 to -0.0

117 ory systolic BP, flow-mediated dilation, and total cholesterol/HDL cholesterol.

118 rial LDL-C levels, non-HDL-C levels, and the total cholesterol/HDL-C ratio were positively associated

119 CI: -1.48%, 0.24%)] was not significant, the total cholesterol:HDL cholesterol ratio was 0.13 (95% CI

120 ain intake and statin use in relation to the total cholesterol:HDL-cholesterol ratio (P-interaction =

121 The non-HDL-cholesterol concentration and total cholesterol:HDL-cholesterol ratio were calculated.

122 95% CI: -0.9%, 5.6%), respectively], and the total-cholesterol:HDL-cholesterol ratio [-0.0% (95% CI:

123 -3-methylglutaryl-CoA reductase activity and total cholesterol hepatic levels were 31 and 10% higher,

124 mption, body mass index, and serum levels of total cholesterol, high- and low-density lipoprotein cho

125 parameters such as fasting glucose, insulin, total cholesterol, high-density lipoprotein (HDL) choles

126 standard definitions of abnormal values for total cholesterol, high-density lipoprotein (HDL) choles

127 ssociation between preeclampsia and maternal total cholesterol, high-density lipoprotein cholesterol

128 Total cholesterol, high-density lipoprotein cholesterol,

129 udy conducted admixture mapping analysis for total cholesterol, high-density lipoprotein cholesterol,

130 ircumference (WC), and fasting blood sample (total cholesterol, high-density lipoprotein cholesterol,

131 rmone therapy use, diastolic blood pressure, total cholesterol, high-density lipoprotein cholesterol,

132 and neutrophil counts and increase in hsCRP, total cholesterol, high-density lipoprotein, and low-den

133 we classified LA using data set quartiles of total cholesterol/high-density lipoprotein cholesterol,

134 ed to evaluate associations of triglyceride, total cholesterol/high-density lipoprotein-cholesterol (

135 sor is successfully used for the analysis of total cholesterol in human serum and butter.

136 old for the amperometric sensing of H2O2 and total cholesterol in human serum are described.

137 intermediate sterol pathway metabolites and total cholesterol in macrophages.

138 lead GWAS variants) strongly associated with total cholesterol in medium-sized HDL (e.g., rs17315646,

139 decreased levels of plasma triglyceride and total cholesterol in ob/ob mice.

140 ary cortisol, plasma interleukin (IL)-6, and total cholesterol in response to standardized mental str

141 e analytical performance for the analysis of total cholesterol in serum (limit of detection (LOD) = 2

142 eroxide (0-5 mM, 2.72 x 10(-6) A.mM(-1)) and total cholesterol in serum from 0 to 9 mM (1.34 x 10(-8)

143 ignificantly greater effect for both LDL and total cholesterol in subjects with diabetes compared wit

144 negatively correlated with triglycerides and total cholesterol in T2D.

145 sex, smoking, blood pressure, diabetes, and total cholesterol; in the non-laboratory (office-based)

146 otein convertase subtilisin/kexin type 9 and total cholesterol increased rapidly and were maintained

147 cant improvements in triglycerides, LDL- and total cholesterol, insulin, HbA1c and HOMA-IR (p < 0.005

148 tive global assessment score and lower serum total cholesterol, LDL cholesterol, and albumin concentr

149 Plasma glucose, total cholesterol, LDL cholesterol, and insulin levels d

150 MI, hemoglobin A1c, systolic blood pressure, total cholesterol, LDL cholesterol, and triglycerides bu

151 Total cholesterol, LDL cholesterol, apoB, and triacylgly

152 Tree nut intake lowers total cholesterol, LDL cholesterol, ApoB, and triglyceri

153 uantitative insulin-sensitivity check index, total cholesterol, LDL cholesterol, HDL cholesterol, or

154 Body weight, BMI, fat mass, total cholesterol, LDL-C and triglyceride concentrations

155 ort an association analysis of lipid traits (total cholesterol, LDL-cholesterol, HDL-cholesterol trig

156 oxidized vegetable ghee increases the serum total cholesterol, LDL-cholesterols, triglycerides and d

157 g populations without marked hyperlipidemia (total cholesterol level <200 mg/dL); absolute benefits w

158 CI, -4.30 to -0.85]; 13 trials [n = 5554]), total cholesterol level (-2.85 mg/dL [95% CI, -4.95 to -

159 No association was found between the total cholesterol level and PIB index.

160 0.36 to 2.76 mm Hg), respectively (n = 12); total cholesterol level decreased by 0.24 mmol/L (9.37 m

161 The changes in total cholesterol level did not reach statistical signif

162 centage of adults with diabetes and the mean total cholesterol level did not vary by income.

163 Total cholesterol level was 3.6 mmol/L (normal, <5.0 mmo

164 mg/L or higher, the association of CHD with total cholesterol level was borderline significant (haza

165 s 383 cells/microL), lipid levels (mean [SD] total cholesterol level, 167 [63] vs 190 [54] mg/dL, and

166 ertension, diabetes, cardiovascular disease, total cholesterol level, and other eye conditions.

167 erlipidemia, ischemic heart disease, stroke, total cholesterol level, body mass index, status of smok

168 al site, education level, physical activity, total cholesterol level, high-density lipoprotein choles

169 examination year, body mass index, smoking, total cholesterol level, systolic blood pressure, diabet

170 um total cholesterol (mmol/L), and change in total cholesterol level.

171 ession variant was associated with decreased total cholesterol levels (P=0.006) with the largest redu

172 rence, -0.7 to 0 mmol/L [-28 to 0 mg/dL] for total cholesterol levels and -0.6 to 0.1 mmol/L [-22 to

173 rosis accompanied by a 17.5-fold increase in total cholesterol levels and a 3-fold increase in lactos

174 s77878271 as a novel variant affecting serum total cholesterol levels and cardiovascular risk.

175 ion study locus for lipid traits, influences total cholesterol levels and is associated with myocardi

176 resulted in significant reductions in plasma total cholesterol levels and suppression of diet-induced

177 d an exceptional 50% reduction in the plasma total cholesterol levels compared to the control group.

178 Total cholesterol levels did not modify the association

179 ow that PF-06446846 reduces plasma PCSK9 and total cholesterol levels in rats following oral dosing.

180 Fasting serum total cholesterol levels were reduced (-12%; p = 0.01) a

181 blood pressure, low-density lipoprotein and total cholesterol levels, and adiposity, with evidence o

182 rds modeling, patients achieving recovery of total cholesterol levels, defined as a median or greater

183 nic deletions associate with reduced LDL and total cholesterol levels.

184 by significant reductions in serum Pcsk9 and total cholesterol levels.

185 significant changes in liver LDLR or plasma total cholesterol levels.

186 ely 40% of children had intermediate or poor total cholesterol levels.

187 ize, as well as increased hepatic and plasma total cholesterol levels.

188 gh-density and low-density lipoproteins, and total cholesterol levels.

189 hazelnuts, and Brazil nuts) on blood lipids [total cholesterol, low-density lipoprotein (LDL) cholest

190 The primary outcomes were: blood pressure, total cholesterol, low-density lipoprotein (LDL) cholest

191 ss index (BMI), fasting blood triglycerides, total cholesterol, low-density lipoprotein (LDL), high-d

192 Serum lipids (total cholesterol, low-density lipoprotein [LDL], high-d

193 C-reactive protein, total cholesterol, low-density lipoprotein and high-dens

194 The association between lipid markers (total cholesterol, low-density lipoprotein cholesterol [

195 Reductions in total cholesterol, low-density lipoprotein cholesterol,

196 No between-group differences were shown for total cholesterol, low-density lipoprotein cholesterol,

197 Also, total cholesterol, low-density lipoprotein cholesterol,

198 bolic traits (fasting insulin, triglyceride, total cholesterol, low-density lipoprotein cholesterol,

199 Total cholesterol, low-density lipoprotein, high-density

200 ssociated with circulating fasting levels of total cholesterol, low-density lipoprotein-cholesterol,

201 ZNF259/APOA5, KANK2/DOCK6 and NCAN/MAU2 for total cholesterol, LPL, ABCA1, ZNF259/APOA5, LIPC and CE

202 king, body mass index <25 kg/m(2), untreated total cholesterol <200 mg/dL, untreated blood pressure <

203 and 4 health factors (nonsmoking, untreated total cholesterol <200 mg/dL, untreated blood pressure <

204 00 mg/dl, glycosylated hemoglobin <5.7%, and total cholesterol <200 mg/dl.

205 e <140/90 mm Hg, fasting glucose <126 mg/dl, total cholesterol <240 mg/dl, low-density lipoprotein ch

206 pressure </=120/</=80 mm Hg, untreated serum total cholesterol <5.18 mmol/l, not smoking, body mass i

207 an difference [MD] -1.3, 95% CI -2.3, -0.2), total cholesterol (MD -8.5 mg/dl, 95% CI -9.5, -7.4) and

208 l/L; 95% CI: 0.07, 0.15 mmol/L; P < 0.0001], total cholesterol (MD: 0.16 mmol/L; 95% CI: 0.10, 0.24 m

209 Hg (95% CI: -5.72, -0.22 mm Hg), P = 0.05], total cholesterol [MD: -0.08 mmol/L (95% CI: -0.16, -0.0

210 Compared with controls, cases had higher total cholesterol (mean difference (MD) = 2.4 mg/dL, 95%

211 olorectal cancer risk with statin use, serum total cholesterol (mmol/L), and change in total choleste

212 Preeclampsia was associated with elevated total cholesterol, non-HDL-C, and triglyceride levels, r

213 develop preeclampsia have elevated levels of total cholesterol, non-HDL-C, and triglycerides during a

214 ween-group differences were also observed in total cholesterol, non-high-density lipoprotein choleste

215 Ps = 10), body mass index (BMI, NSNPs = 32), total cholesterol (NSNPs = 73), HDL-cholesterol (NSNPs =

216 More blood tests (eg, total cholesterol, odds ratio [OR] 1.88, 95% CI 1.47-2.4

217 omized to EFV had a reduced risk of elevated total cholesterol (OR 0.45 95% CI: 0.27-0.75, P = .002)

218 4; 95% CI, 0.65-0.84, per 10 mmHg increase), total cholesterol (OR, 0.87; 95% CI, 0.80-0.95, per mmol

219 fasting plasma triglyceride (p < 0.001) and total cholesterol (p < 0.05).

220 found evidence of a smaller causal effect on total cholesterol (P for difference = 0.015) in the >/=5

221 ve sleepiness (p=0.024), mobility (p=0.029), total cholesterol (p=0.048), and LDL cholesterol (p=0.04

222 gnificant associations for genetic scores of total cholesterol (P=3.6x10(-)(6)), low-density lipoprot

223 anoate (PFOA) was positively associated with total cholesterol [percent median change per log10-unit

224 roup had a greater (mean +/- SD) decrease in total cholesterol (PY = -0.36 +/- 0.10 mmol/L, LF = -0.3

225 /d reduced low-density lipoprotein (LDL) and total cholesterol relative to control by 0.25 mmol/L (95

226 des used for selective detection of free and total cholesterol respectively in the range of 0.12-12.9

227 A mM(-1) cm(-2) towards free cholesterol and total cholesterol respectively with response time of 5 s

228 lasma lipids, whereas the MFGM diet did not [total cholesterol (+/-SD): +0.30 +/- 0.49 compared with

229 ayer, we find that between 50 and 60% of the total cholesterol should be in the inner leaf of human e

230 The joint effect of total cholesterol SNPs, low-density lipoprotein SNPs, an

231 showing differential methylation related to total cholesterol (SREBF2), HDL-cholesterol (PHOSPHO1, S

232 this study is to examine whether high serum total cholesterol (STC) is associated with periodontitis

233 ntake, high-density lipoprotein-cholesterol, total cholesterol, systolic blood pressure, and waist ci

234 ), a 30% decrease reflecting improvements in total cholesterol, systolic blood pressure, smoking, and

235 Plasma levels of total cholesterol (T-CHL), low density lipoprotein-chole

236 400/100 mg twice daily) monotherapy, fasting total cholesterol (TC) >/=200 mg/dL or low-density lipop

237 Adverse concentrations of total cholesterol (TC) (>/= 200 mg/dL), high-density lip

238 (95% confidence interval [CI]) for AMI among total cholesterol (TC) 200-239 stratum were 5.3 (4.89, 5

239 lipoprotein (LDL), plasma concentrations of total cholesterol (TC) and triglycerides (TG)).

240 also found between GCK CpG4 methylation and total cholesterol (TC) concentration (r=0.304, P=0.036).

241 rom a cohort of children with elevated serum total cholesterol (TC) concentration, detected in a nati

242 Mean total cholesterol (TC) decreased from 165 to 160 mg/dl,

243 w density lipoprotein cholesterol (LDLc) and total cholesterol (TC) in individuals at higher risk for

244 uced body weight, hepatic and plasma TG, and total cholesterol (TC) levels.

245 rial dyslipidemia, characterized by elevated total cholesterol (TC) or low-density lipoprotein choles

246 At endpoint, total cholesterol (TC) was lowest after the FlaxSaff pha

247 density lipoprotein cholesterol (LDL-C) and total cholesterol (TC) were obtained in pretreatment ser

248 The HF diet increased the serum leptin and total cholesterol (TC) with respect to the control level

249 lele (varepsilon4) is associated with higher total cholesterol (TC), amplified response to saturated

250 ects of systolic blood pressure (SBP), serum total cholesterol (TC), fasting plasma glucose (FPG), an

251 Circulating lipid panels including total cholesterol (TC), HDL cholesterol, and triglycerid

252 or placebo (n = 190) groups and assessed for total cholesterol (TC), high density lipoprotein (HDL) a

253 d with fasting cholesterol levels, including total cholesterol (TC), high-density lipoprotein cholest

254 ts in 250 loci significantly associated with total cholesterol (TC), high-density-lipoprotein cholest

255 red with non-whole-grain foods on changes in total cholesterol (TC), LDL cholesterol, HDL cholesterol

256 total red meat/d on CVD risk factors [blood total cholesterol (TC), LDL cholesterol, HDL cholesterol

257 Total cholesterol (TC), LDL cholesterol, triacylglycerol

258 ctions in body weight, blood glucose levels, total cholesterol (TC), leptin, total and direct bilirub

259 ast one of the following CHD/CVD biomarkers: total cholesterol (TC), low-density lipoprotein (LDL) ch

260 s measured included serum triglyceride (TG), total cholesterol (TC), low-density lipoprotein (LDL) ch

261 Total cholesterol (TC), low-density lipoprotein choleste

262 t role in modulating lipid traits, including total cholesterol (TC), low-density lipoprotein choleste

263 carriers had higher plasma concentrations of total cholesterol (TC), low-density lipoprotein choleste

264 Rilpivirine produced minimal changes in total cholesterol (TC), low-density lipoprotein-choleste

265 Serum levels of total cholesterol (TC), TG, low-density lipoprotein, and

266 PS consumption lowered total cholesterol (TC; -0.25 +/- 0.05 mmol/L; P < 0.0001

267 low-density lipoprotein cholesterol [LDL-C], total cholesterol [TC]) were studied as continuous varia

268 ERIAL/METHODS: Glycated haemoglobin (HbA1c), total cholesterol (TCH), high- and low-density cholester

269 group, BOP was significantly correlated with total cholesterol, the ratio of total cholesterol to hig

270 tically significant decrease in the ratio of total cholesterol to HDL cholesterol at 24 weeks in all

271 intervention prevented the elevated ratio of total cholesterol to HDL cholesterol in the fasted serum

272 (sex, age, cohort status, diabetes duration, total cholesterol to HDL-cholesterol ratio, smoking, sys

273 en the two groups in change from baseline in total cholesterol to HDL-cholesterol ratio.

274 The total cholesterol to high-density lipoprotein cholestero

275 related with total cholesterol, the ratio of total cholesterol to high-density lipoprotein cholestero

276 protein cholesterol (-11.3% and -13.6%), and total cholesterol to high-density lipoprotein cholestero

277 ascular and cardiac events, digoxin use, and total cholesterol to high-density lipoprotein cholestero

278 d diastolic blood pressure, ratio of fasting total cholesterol to high-density lipoprotein cholestero

279 cantly decreased plasma insulin, HOMA index, total cholesterol, triglyceride, LDL and visceral fat.

280 m exhibited a significant decrease in plasma total cholesterol, triglycerides and LDL cholesterol com

281 either directly measured or calculated from total cholesterol, triglycerides, and apoA-I.

282 pressure, LDL cholesterol, HDL cholesterol, total cholesterol, triglycerides, and fasting blood gluc

283 Comparable increases occurred in total cholesterol, triglycerides, and low-density lipopr

284 Only the ethyl acetate extract reduced total cholesterol, triglycerides, and low-density lipopr

285 Sweden, with measurements of serum glucose, total cholesterol, triglycerides, apolipoprotein B (apoB

286 blood pressure, low-density lipoprotein- and total cholesterol, triglycerides, fasting glucose, body

287 , creatinine, uric acid, albumin, bilirubin, total cholesterol, triglycerides, high-density lipoprote

288 ons of LDL cholesterol, non-HDL cholesterol, total cholesterol, triglycerides, lipoprotein(a), and HD

289 wn from each to determine the lipid profile (total cholesterol, triglycerides, low-density lipoprotei

290 h fat-fed mice without affecting circulating total cholesterol, triglycerides, or glycerol levels.

291 ase system and a chemiluminescence assay for total cholesterol using cholesterol esterase/cholesterol

292 tein cholesterol [LDL-c], triglycerides, and total cholesterol) using well-established SNPs in 157 lo

293 All fibres reviewed reduced total cholesterol, very low-density lipoprotein choleste

294 e in dietary fat intake on concentrations of total cholesterol was estimated by the use of equations

295 Total cholesterol was inversely associated with incident

296 y lipoprotein, high-density lipoprotein, and total cholesterol were not associated with microorganism

297 liver were reduced, whereas tissue levels of total cholesterol were unchanged.

298 es in the association of body mass index and total cholesterol with AF need to be evaluated for under

299 of high-density lipoprotein cholesterol and total cholesterol with AMD.

300 -based) risk score, we replaced diabetes and total cholesterol with BMI.